{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T16:43:48Z","timestamp":1790700228731,"version":"4.1.0"},"reference-count":74,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Malar J"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s12936-017-1963-0","type":"journal-article","created":{"date-parts":[[2017,8,3]],"date-time":"2017-08-03T08:41:56Z","timestamp":1501749716000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":40,"title":["Comparison of anti-malarial drug efficacy in the treatment of uncomplicated malaria in African children and adults using network meta-analysis"],"prefix":"10.1186","volume":"16","author":[{"given":"Solange","family":"Whegang Youdom","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachida","family":"Tahar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonardo K.","family":"Basco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,8,3]]},"reference":[{"key":"1963_CR1","unstructured":"WHO. Global anti-malarial drug policy database Africa. Technical report. Geneva: World Health Organization; 2006."},{"key":"1963_CR2","unstructured":"WHO. Guidelines for the treatment of malaria. Technical report. Geneva: World\u00a0Health Organization; 2006."},{"key":"1963_CR3","unstructured":"WHO. Guidelines for the treatment of malaria. Geneva: World Health Organization; 2015."},{"key":"1963_CR4","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1056\/NEJMc0900231","volume":"361","author":"H Noedl","year":"2009","unstructured":"Noedl H, Socheat D, Satimai W. Artemisinin-resistant malaria in Asia. N Engl J Med. 2009;361:540\u20131.","journal-title":"N Engl J Med"},{"key":"1963_CR5","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1056\/NEJMoa1314981","volume":"371","author":"EA Ashley","year":"2014","unstructured":"Ashley EA, Dhorda M, Fairhurst RM, Amaratunga C, Lim P, Suon S, et al. Spread of artemisinin resistance in Plasmodium falciparum malaria. N Engl J Med. 2014;371:411\u201323.","journal-title":"N Engl J Med"},{"key":"1963_CR6","unstructured":"WHO. Assessment and monitoring of antimalarial drug efficacy for the treatment of uncomplicated falciparum malaria. Geneva: World Health Organization; 2003."},{"key":"1963_CR7","unstructured":"WHO. Guidelines for the treatment of malaria. 3rd edition. Geneva: World Health Organization; 2009."},{"key":"1963_CR8","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1186\/1475-2875-11-260","volume":"11","author":"J Zwang","year":"2012","unstructured":"Zwang J, Dorsey G, Djimd\u00e9 A, Karema C, Martensson A, Ndiaye JL, et al. Clinical tolerability of ASAQ vs comparator treatments for uncomplicated falciparum malaria: an individual patient analysis of height randomized clinical trials in sub Saharan Africa. Malar J. 2012;11:260.","journal-title":"Malar J."},{"key":"1963_CR9","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1186\/1475-2875-13-114","volume":"13","author":"J Zwang","year":"2014","unstructured":"Zwang J, Dorsey G, M\u00e5rtensson A, d\u2019Alessandro U, Ndiaye JL, Karema C, et al. Plasmodium falciparum clearance in clinical studies of artesunate\u2013amodiaquine and comparator treatments in sub-Saharan Africa, 1999\u20132009. Malar J. 2014;13:114.","journal-title":"Malar J."},{"key":"1963_CR10","doi-asserted-by":"publisher","first-page":"CD010927","DOI":"10.1002\/14651858.CD010927","volume":"1","author":"B Zani","year":"2014","unstructured":"Zani B, Gathu M, Donegan S, Oliiaro PL, Sinclair D. Dihydroartemisinin\u2013piperaquine for treating uncomplicated Plasmodium falciparum malaria. Cochrane Database Syst Rev. 2014;1:CD010927. doi: 10.1002\/14651858.CD010927 .","journal-title":"Cochrane Database Syst Rev."},{"key":"1963_CR11","doi-asserted-by":"publisher","first-page":"CD006404","DOI":"10.1002\/14651858.CD006404.pub2","volume":"1","author":"H Bukirwa","year":"2014","unstructured":"Bukirwa H, Unnikrishnan B, Kramer CV, Sinclair D, Nair S, Tharyan P. Artesunate plus pyronaridine for treating uncomplicated Plasmodium falciparum malaria (review). Cochrane Database Syst Rev. 2014;1:CD006404. doi: 10.1002\/14651858.CD006404.pub2 .","journal-title":"Cochrane Database Syst Rev."},{"key":"1963_CR12","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1186\/s12916-015-0445-x","volume":"13","author":"WWARN Artemisinin based Combination Therapy (ACT) Africa Baseline Study Group","year":"2015","unstructured":"WWARN Artemisinin based Combination Therapy (ACT) Africa Baseline Study Group. Clinical determinants of early parasitological response to ACTs in African patients with uncomplicated falciparum malaria: a literature review and meta-analysis of individual patient data. BMC Med. 2015;13:212.","journal-title":"BMC Med"},{"key":"1963_CR13","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1186\/s12916-016-0621-7","volume":"14","author":"WWARN Artemisinin based Combination Therapy (ACT) Africa Baseline Study\u00a0Group","year":"2016","unstructured":"WWARN Artemisinin based Combination Therapy (ACT) Africa Baseline Study\u00a0Group. Gametocyte carriage in uncomplicated Plasmodium falciparum malaria following treatment with artemisinin combination therapy: a systematic review and meta-analysis of individual patient data. BMC Med. 2016;14:79.","journal-title":"BMC Med."},{"key":"1963_CR14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta9260","volume":"9","author":"AM Glenny","year":"2005","unstructured":"Glenny AM, Altman DG, Song F, Sakarovitch C, Deeks JJ, D\u2019Amico R, et al. Indirect comparisons of competing interventions. Health Technol Assess. 2005;9:1\u2013134.","journal-title":"Health Technol Assess"},{"key":"1963_CR15","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1002\/jrsm.1037","volume":"3","author":"G Salanti","year":"2012","unstructured":"Salanti G. Indirect and mixed-treatment comparison, network, or multiple-treatments meta-analysis: many names, many benefits, many concerns for the next generation evidence synthesis tool. Res Synth Methods. 2012;3:80\u201397.","journal-title":"Res Synth Methods"},{"key":"1963_CR16","doi-asserted-by":"crossref","first-page":"3675","DOI":"10.1136\/bmj.f3675","volume":"347","author":"A Bafeta","year":"2013","unstructured":"Bafeta A, Trinquart L, Seror R, Ravaud P. Analysis of the systematic reviews process in reports of network meta-analysis: methodological systematic review. BMJ. 2013;347:3675.","journal-title":"BMJ"},{"key":"1963_CR17","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.jclinepi.2013.07.014","volume":"67","author":"AW Lee","year":"2014","unstructured":"Lee AW. Review of mixed treatment comparisons in published systematic reviews shows marked increase since 2009. J Clin Epidemiol. 2014;67:138\u201343.","journal-title":"J Clin Epidemiol"},{"key":"1963_CR18","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1186\/2046-4053-3-109","volume":"3","author":"DM Caldwell","year":"2014","unstructured":"Caldwell DM. An overview of conducting systematic reviews with network meta-analysis. Sys Rev. 2014;3:109.","journal-title":"Sys Rev."},{"key":"1963_CR19","doi-asserted-by":"crossref","first-page":"3105","DOI":"10.1002\/sim.1875","volume":"23","author":"G Lu","year":"2004","unstructured":"Lu G, Ades AE. Combination of direct and indirect evidence in mixed treatment comparisons. Stat Med. 2004;23:3105\u201324.","journal-title":"Stat Med"},{"key":"1963_CR20","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1136\/bmj.331.7521.897","volume":"331","author":"DM Caldwell","year":"2005","unstructured":"Caldwell DM, Ades AE, Higgins JPT. Simultaneous comparison of multiple treatments: combining direct and indirect evidence. BMJ. 2005;331:897\u2013900.","journal-title":"BMJ"},{"key":"1963_CR21","unstructured":"van Valkenhoef G, Kuiper J. Gemtc: network meta-analysis using Bayesian methods. 2014. R package version 0.6-1."},{"key":"1963_CR22","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1186\/1475-2875-11-147","volume":"11","author":"SW Youdom","year":"2012","unstructured":"Youdom SW, Samson A, Basco LK, Thalabard JC. Multiple treatment comparisons in a series of anti-malarial trials with an ordinal primary outcome and repeated treatment evaluations. Malar J. 2012;11:147.","journal-title":"Malar J."},{"key":"1963_CR23","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1002\/jrsm.1085","volume":"4","author":"S Donegan","year":"2013","unstructured":"Donegan S, Williamson P, D\u2019Alessandro U, Smith CT. Assessing key assumptions of network meta-analysis: a review of methods. Res Synth Methods. 2013;4:291\u2013323.","journal-title":"Res Synth Methods."},{"key":"1963_CR24","doi-asserted-by":"crossref","first-page":"e7164","DOI":"10.1371\/journal.pone.0007164","volume":"4","author":"B Cisse","year":"2009","unstructured":"Cisse B, Cairns M, Faye E, NDiaye O, Faye B, Cames C, et al. Randomized trial of piperaquine with sulfadoxine\u2013pyrimethamine or dihydroartemisinin for malaria intermittent preventive treatment in children. PLoS ONE. 2009;4:e7164.","journal-title":"PLoS ONE"},{"key":"1963_CR25","doi-asserted-by":"crossref","first-page":"e11225","DOI":"10.1371\/journal.pone.0011225","volume":"5","author":"K Bojang","year":"2010","unstructured":"Bojang K, Akor F, Bittaye O, Conway D, Bottomley C, Milligan P, et al. A randomized trial to compare the safety, tolerability and efficacy of three drug combinations for intermittent preventive treatment in children. PLoS ONE. 2010;5:e11225.","journal-title":"PLoS ONE"},{"key":"1963_CR26","doi-asserted-by":"crossref","first-page":"e0151565","DOI":"10.1371\/journal.pone.0151565","volume":"11","author":"P Sondo","year":"2016","unstructured":"Sondo P, Derra K, Nakanabo SD, Tarnagda Z, Kazienga A, Zampa O, et al. Artesunate\u2013amodiaquine and artemether\u2013lumefantrine therapies and selection of Pfcrt and Pfmdr1 alleles in Nanoro, Burkina Faso. PLoS One. 2016;11:e0151565.","journal-title":"PLoS One."},{"key":"1963_CR27","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1186\/s12936-015-0620-8","volume":"14","author":"R Chandra","year":"2015","unstructured":"Chandra R, Ansah P, Sagara I, Sie A, Tiono AB, Djimde AA, et al. Comparison of azithromycin plus chloroquine versus artemether\u2013lumefantrine for the treatment of uncomplicated Plasmodium falciparum malaria in children in Africa: a randomized, open-label study. Malar J. 2015;14:108.","journal-title":"Malar J."},{"key":"1963_CR28","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1186\/s12936-015-0649-8","volume":"10","author":"A Shayo","year":"2015","unstructured":"Shayo A, Buza J, Ishengoma DS. Monitoring of efficacy and safety of artemisinin-based anti-malarial for treatment of uncomplicated malaria: a review of evidence of implementation of anti-malarial therapeutic efficacy trials in Tanzania. Malar J. 2015;10:135.","journal-title":"Malar J."},{"issue":"Suppl 1","key":"1963_CR29","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1186\/1475-2875-8-S1-S5","volume":"8","author":"M Makanga","year":"2009","unstructured":"Makanga M, Krudsood S. The clinical efficacy of artemether\/lumefantrine (Coartem). Malar J. 2009;8(Suppl 1):S5.","journal-title":"Malar J."},{"key":"1963_CR30","doi-asserted-by":"crossref","first-page":"e553772","DOI":"10.1371\/journal.pone.0053772","volume":"8","author":"A Yeka","year":"2013","unstructured":"Yeka A, Tibenderana J, Achan J, D\u2019Alessandro U, Talisuna AO. Efficacy of quinine, artemether\u2013lumefantrine and dihydroartemisinin\u2013piperaquine as rescue treatment for uncomplicated malaria in Ugandan children. PLoS ONE. 2013;8:e553772.","journal-title":"PLoS ONE"},{"key":"1963_CR31","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1007\/s13149-012-0211-7","volume":"105","author":"D Kinde-Gazard","year":"2012","unstructured":"Kinde-Gazard D, Ogouy\u00e8mi-Hounto A, Capo-Chichi L, Gbaguidi J, Massougbodji A. Essai clinique randomis\u00e9 comparant l\u2019efficacit\u00e9 et la tol\u00e9rance de la combinaison art\u00e9misinine-naphthoquine (Arco\u00ae) et art\u00e9m\u00e9ther-lum\u00e9fantrine (Coartem\u00ae) dans le traitement du paludisme simple au B\u00e9nin. Bull Soc Path Exot. 2012;105:208\u201314.","journal-title":"Bull Soc Path Exot."},{"key":"1963_CR32","first-page":"45","volume":"10","author":"D Sow","year":"2016","unstructured":"Sow D, Ndiaye JL, Sylla K, Ba MS, Tine RC, Faye B, et al. Evaluation of the efficacy and safety of three 2-drug combinations for the treatment of uncomplicated Plasmodium falciparum malaria in Senegal: artesunate\u2013amodiaquine, dihydroartemisinin\u2013piperaquine, and artemether\u2013lumefantrine. Med Sante Trop. 2016;10:45\u201350 (in French).","journal-title":"Med Sante Trop."},{"key":"1963_CR33","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1177\/0272989X12458724","volume":"33","author":"S Dias","year":"2013","unstructured":"Dias S, Sutton AJ, Ades AE, Welton NJ. Evidence synthesis for decision making 2: a generalized linear modeling framework for pairwise and network meta-analysis of randomized controlled trials. Med Decis Mak. 2013;33:607\u201317.","journal-title":"Med Decis Mak"},{"key":"1963_CR34","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1177\/0962280213500185","volume":"25","author":"T Greco","year":"2013","unstructured":"Greco T, Landoni G, Biondi-Zoccai G, D\u2019Ascenzo F, Zangrillo A. A Bayesian network meta-analysis for binary outcome: how to do it. Stat Methods Med Res. 2013;25:1757\u201373.","journal-title":"Stat Methods Med Res"},{"key":"1963_CR35","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1177\/0272989X13481110","volume":"33","author":"H Hong","year":"2013","unstructured":"Hong H, Carlin BP, Shamliyan TA, Wyman JF, Ramakrishnan R, Sainfort F, et al. Comparing Bayesian and frequentist approaches for multiple outcome mixed treatment comparisons. Med Decis Mak. 2013;33:702\u201314.","journal-title":"Med Decis Mak"},{"key":"1963_CR36","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/S0895-4356(97)00049-8","volume":"50","author":"HC Bucher","year":"1997","unstructured":"Bucher HC, Guyatt GH, Griffith LE, Walter SD. The results of direct and indirect treatment comparisons in meta-analysis of randomized controlled trials. J Clin Epidemiol. 1997;50:683\u201391.","journal-title":"J Clin Epidemiol"},{"key":"1963_CR37","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1016\/S0140-6736(05)66417-3","volume":"365","author":"TK Mutabingwa","year":"2005","unstructured":"Mutabingwa TK, Anthony D, Heller A, Hallett R, Ahmed J, Drakeley C, Greenwood BM, Whitty CJ. Amodiaquine alone, amodiaquine\u00a0+\u00a0sulfadoxine\u2013pyrimethamine, amodiaquine\u00a0+\u00a0artesunate, and artemether\u2013lumefantrine for outpatient treatment of malaria in Tanzanian children: a four-arm randomized effectiveness trial. Lancet. 2005;365:1474\u201380.","journal-title":"Lancet"},{"key":"1963_CR38","doi-asserted-by":"crossref","first-page":"e7","DOI":"10.1371\/journal.pctr.0010007","volume":"1","author":"H Bukirwa","year":"2006","unstructured":"Bukirwa H, Yeka A, Kamya MR, Talisuna A, Banek K, Bakyaita N, et al. Artemisinin combination therapies for treatment of uncomplicated malaria in Uganda. PLoS Clin Trials. 2006;1:e7.","journal-title":"PLoS Clin Trials."},{"key":"1963_CR39","doi-asserted-by":"crossref","first-page":"2210","DOI":"10.1001\/jama.297.20.2210","volume":"297","author":"G Dorsey","year":"2007","unstructured":"Dorsey G, Staedke S, Clark TD, Njama-Meya D, Nzarubara B, Maiteki-Sebuguzi C, et al. Combination therapy for uncomplicated falciparum malaria in Ugandan children. JAMA. 2007;297:2210\u20139.","journal-title":"JAMA"},{"key":"1963_CR40","doi-asserted-by":"crossref","first-page":"235","DOI":"10.4269\/ajtmh.2007.77.235","volume":"77","author":"A Sowunmi","year":"2007","unstructured":"Sowunmi A, Gbotosho GO, Happi CT, Adedeji AA, Fehintola FA, Folarin OA, et al. Therapeutic efficacy and effects of artemether\/lumefantrine and amodiaquine\u2013sulfalene\u2013pyrimethamine on gametocyte carriage in children with uncomplicated Plasmodium falciparum malaria in southwestern Nigeria. Am J Trop Med Hyg. 2007;77:235\u201341.","journal-title":"Am J Trop Med Hyg"},{"key":"1963_CR41","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.trstmh.2006.06.010","volume":"101","author":"CI Fanello","year":"2007","unstructured":"Fanello CI, Karema C, van Doren W, Van Overmeir C, Ngamije D, D\u2019Alessandro U. A randomized trial to assess the safety and efficacy of artemether\/lumefantrine for the treatment of uncomplicated Plasmodium falciparum malaria in Rwanda. Trans R Soc Trop Med Hyg. 2007;101:344\u201350.","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"1963_CR42","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1086\/522985","volume":"14","author":"I Zongo","year":"2007","unstructured":"Zongo I, Dorsey G, Rouamba N, Dokomajilar C, Sere Y, Rosenthal PJ, et al. Randomized comparison of amodiaquine plus sulfadoxine\u2013pyrimethamine, artemether\u2013lumefantrine, and dihydroartemisinin\u2013piperaquine for the treatment of uncomplicated Plasmodium falciparum malaria in Burkina Faso. Clin Infect Dis. 2007;14:1453\u201361.","journal-title":"Clin Infect Dis"},{"key":"1963_CR43","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/1475-2875-13-9","volume":"13","author":"D Djalle","year":"2014","unstructured":"Djalle D, Njuimo SP, Manirakiza A, Laganier R, Faou A, Rogier C. Efficacy and safety of artemether\u00a0+\u00a0lumefantrine, artesunate\u00a0+\u00a0sulphamethoxypyrazine\u2013pyrimethamine and artesunate\u00a0+\u00a0amodiaquine and sulphadoxine\u2013pyrimethamine\u00a0+\u00a0amodiaquine in the treatment of uncomplicated falciparum malaria in Bangui, Central African Republic: a randomized trial. Malar J. 2014;13:9.","journal-title":"Malar J."},{"key":"1963_CR44","doi-asserted-by":"crossref","first-page":"e13438","DOI":"10.1371\/journal.pone.0013438","volume":"5","author":"J Nankabirwa","year":"2010","unstructured":"Nankabirwa J, Cundill B, Clarke S, Kabatereine N, Rosenthal PJ, Dorsey G, et al. Efficacy, safety, and tolerability of three regimens for prevention of malaria: a randomized, placebo- controlled trial in Ugandan schoolchildren. PLoS ONE. 2010;5:e13438.","journal-title":"PLoS ONE"},{"key":"1963_CR45","doi-asserted-by":"crossref","first-page":"4387","DOI":"10.1128\/AAC.04923-14","volume":"59","author":"I Zongo","year":"2015","unstructured":"Zongo I, Milligan P, Compaore YD, Some AF, Greenwood B, Tarning J, et al. Randomized non-inferiority trial of dihydroartemisinin\u2013piperaquine compared with sulfadoxine\u2013pyrimethamine plus amodiaquine for seasonal malaria chemoprevention in Burkina Faso. Antimicrob Agents Chemother. 2015;59:4387\u201396.","journal-title":"Antimicrob Agents Chemother"},{"key":"1963_CR46","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1186\/1475-2875-11-433","volume":"11","author":"B Faye","year":"2012","unstructured":"Faye B, Ku\u00e9t\u00e9 T, Kiki-Barro CP, Tine RC, Nkoa T, Ndiaye JL, et al. Multicentre study evaluating the non-inferiority of the new paediatric formulation of artesunate\/amodiaquine versus artemether\/lumefantrine for the management of uncomplicated Plasmodium falciparum malaria in children in Cameroon, Ivory Coast and Senegal. Malar J. 2012;11:433.","journal-title":"Malar J."},{"key":"1963_CR47","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1186\/1475-2875-12-250","volume":"12","author":"B Schramm","year":"2013","unstructured":"Schramm B, Valeh P, Baudin E, Mazinda CS, Smith R, Pinoges L, et al. Tolerability and safety of artesunate\u2013amodiaquine and artemether\u2013lumefantrine fixed dose combinations for the treatment of uncomplicated Plasmodium falciparum malaria: two open-label, randomized trials in Nimba County, Liberia. Malar J. 2013;12:250.","journal-title":"Malar J."},{"key":"1963_CR48","doi-asserted-by":"crossref","first-page":"e113311","DOI":"10.1371\/journal.pone.0113311","volume":"9","author":"A Yeka","year":"2014","unstructured":"Yeka A, Lameyre V, Afizi K, Fredrick M, Lukwago R, Kamya MR. Efficacy and safety of fixed-dose artesunate\u2013amodiaquine vs. artemether\u2013lumefantrine for repeated treatment of uncomplicated malaria in Ugandan children. PLoS ONE. 2014;9:e113311.","journal-title":"PLoS ONE"},{"key":"1963_CR49","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1186\/s12936-015-0843-8","volume":"14","author":"P Sondo","year":"2015","unstructured":"Sondo P, Derra K, Diallo-Nakanabo S, Tarnagda Z, Zampa O, Kazienga A, et al. Effectiveness and safety of artemether\u2013lumefantrine versus artesunate\u2013amodiaquine for unsupervised treatment of uncomplicated falciparum malaria in patients of all age groups in Nanoro, Burkina Faso: a randomized open label trial. Malar J. 2015;14:325.","journal-title":"Malar J."},{"key":"1963_CR50","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s12936-015-1080-x","volume":"15","author":"B Abuaku","year":"2016","unstructured":"Abuaku B, Duah N, Quaye L, Quashie N, Malm K, Bart-Plange C, et al. Therapeutic efficacy of artesunate\u2013amodiaquine and artemether\u2013lumefantrine combinations in the treatment of uncomplicated malaria in two ecological zones in Ghana. Malar J. 2016;15:6.","journal-title":"Malar J."},{"key":"1963_CR51","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1016\/S1473-3099(14)70826-6","volume":"14","author":"C Roper","year":"2014","unstructured":"Roper C, Alifrangis M, Ariey F, Talisuna A, Menard D, Mercereau-Puijalon O, et al. Molecular surveillance for artemisinin resistance in Africa. Lancet Infect Dis. 2014;14:668\u201370.","journal-title":"Lancet Infect Dis."},{"key":"1963_CR52","doi-asserted-by":"crossref","first-page":"e7871","DOI":"10.1371\/journal.pone.0007871","volume":"4","author":"Q Bassat","year":"2009","unstructured":"Bassat Q, Mulenga M, Tinto H, Piola P, Borrmann S, Men\u00e9ndez C, et al. Dihydroartemisinin\u2013piperaquine and artemether\u2013lumefantrine for treating uncomplicated malaria in African children: a randomized, non-inferiority trial. PLoS ONE. 2009;4:e7871.","journal-title":"PLoS ONE"},{"key":"1963_CR53","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1186\/1475-2875-10-198","volume":"10","author":"W Yavo","year":"2011","unstructured":"Yavo W, Faye B, Kuete T, Djohan V, Oga SA, Kassi RR, et al. Multicentric assessment of the efficacy and tolerability of dihydroartemisinin\u2013piperaquine compared to artemether\u2013lumefantrine in the treatment of uncomplicated Plasmodium falciparum malaria in sub-Saharan Africa. Malar J. 2011;10:198.","journal-title":"Malar J."},{"key":"1963_CR54","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/1475-2875-13-32","volume":"13","author":"MK Muhindo","year":"2013","unstructured":"Muhindo MK, Kakuru A, Jagannathan P, Talisuna A, Osilo E, Orukan F, et al. Early parasite clearance following artemisinin based combination therapy among Ugandan children with uncomplicated Plasmodium falciparum malaria. Malar J. 2013;13:32.","journal-title":"Malar J."},{"key":"1963_CR55","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1093\/infdis\/jit077","volume":"207","author":"P Sawa","year":"2013","unstructured":"Sawa P, Shekalaghe SA, Drakeley CJ, Sutherland CJ, Mweresa CK, Baidjoe AY, et al. Malaria transmission after artemether\u2013lumefantrine and dihydroartemisinin\u2013piperaquine: a randomized trial. J Infect Dis. 2013;207:1637\u201345.","journal-title":"J Infect Dis"},{"key":"1963_CR56","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1093\/cid\/ciu286","volume":"59","author":"A Kakuru","year":"2014","unstructured":"Kakuru A, Achan J, Muhindo MK, Ikilez G, Arinaitwe E, Mwangwa F, et al. Artemisinin-based combination therapies are efficacious and safe for treatment of uncomplicated malaria in HIV-infected Ugandan children. Clin Infect Dis. 2014;59:446\u201353.","journal-title":"Clin Infect Dis"},{"key":"1963_CR57","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1093\/cid\/ciu353","volume":"59","author":"H Wanzira","year":"2014","unstructured":"Wanzira H, Kakuru A, Arinaitwe E, Bigira V, Muhindo MK, Conrad M, et al. Longitudinal outcomes in a cohort of Ugandan children randomized to artemether\u2013lumefantrine versus Dihydroartemisinin\u2013piperaquine for the treatment of malaria. Clin Infect Dis. 2014;59:509\u201316.","journal-title":"Clin Infect Dis"},{"key":"1963_CR58","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1111\/j.1365-3156.2010.02701.x","volume":"16","author":"OA Toure","year":"2011","unstructured":"Toure OA, Kouame MG, Didier YJ, Berenger AA, Djerea K, Genevieve GO, et al. Artesunate\/mefloquine paediatric formulation vs. artemether\/lumefantrine for the treatment of uncomplicated Plasmodium falciparum in Anonkoua Kout\u00e9, C\u00f4te d\u2019Ivoire. Trop Med Int Health. 2011;16:290\u20137.","journal-title":"Trop Med Int Health."},{"key":"1963_CR59","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1186\/1475-2875-11-416","volume":"11","author":"RC Tine","year":"2012","unstructured":"Tine RC, Faye B, Sylla K, Ndiaye JL, Ndiaye M, Sow D, et al. Efficacy and tolerability of a new formulation of artesunate\u2013mefloquine for the treatment of uncomplicated malaria in adult in Senegal: open randomized trial. Malar J. 2012;11:416.","journal-title":"Malar J."},{"key":"1963_CR60","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1186\/1475-2875-6-80","volume":"6","author":"B Faye","year":"2007","unstructured":"Faye B, Ndiaye JL, Ndiaye D, Dieng Y, Faye O, Gaye O. Efficacy and tolerability of four anti-malarial combinations in the treatment of uncomplicated Plasmodium falciparum malaria in Senegal. Malar J. 2007;6:80.","journal-title":"Malar J."},{"key":"1963_CR61","doi-asserted-by":"crossref","first-page":"655","DOI":"10.4269\/ajtmh.2008.79.655","volume":"79","author":"I Sagara","year":"2008","unstructured":"Sagara I, Diallo A, Kone M, Coulibaly M, Diawara SI, Guindo O, et al. A randomized trial of artesunate\u2013mefloquine versus artemether\u2013lumefantrine for treatment of uncomplicated Plasmodium falciparum malaria in Mali. Am J Trop Med Hyg. 2008;79:655\u201361.","journal-title":"Am J Trop Med Hyg"},{"key":"1963_CR62","doi-asserted-by":"crossref","first-page":"140","DOI":"10.4269\/ajtmh.2010.09-0265","volume":"82","author":"B Faye","year":"2010","unstructured":"Faye B, Ndiaye JL, Tine R, Sylla K, Gueye A, Lo AC, et al. A randomized trial of artesunate mefloquine versus artemether lumefantrine for the treatment of uncomplicated Plasmodium falciparum malaria in Senegalese children. Am J Trop Med Hyg. 2010;82:140\u20134.","journal-title":"Am J Trop Med Hyg"},{"key":"1963_CR63","doi-asserted-by":"crossref","first-page":"50","DOI":"10.4269\/ajtmh.2012.11-0649","volume":"87","author":"I Sagara","year":"2012","unstructured":"Sagara I, Fofana B, Gaudart J, Sidibe B, Togo A, Toure S, et al. Repeated artemisinin-based combination therapies in a malaria hyperendemic area of Mali: efficacy, safety, and public health impact. Am J Trop Med Hyg. 2012;87:50\u20136.","journal-title":"Am J Trop Med Hyg"},{"key":"1963_CR64","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1186\/1475-2875-10-185","volume":"10","author":"H Menan","year":"2011","unstructured":"Menan H, Faye O, Same-Ekobo A, Oga AS, Faye B, Kiki Barro CP, et al. Comparative study of the efficacy and tolerability of dihydroartemisinin\u2013piperaquine\u2013trimethoprim versus artemether\u2013lumefantrine in the treatment of uncomplicated Plasmodium falciparum malaria in Cameroon, Ivory Coast and Senegal. Malar J. 2011;10:185.","journal-title":"Malar J."},{"key":"1963_CR65","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1159\/000360578","volume":"23","author":"CO Falade","year":"2014","unstructured":"Falade CO, Dada-Adegbola HO, Ogunkunle OO, Oguike MC, Nash O, Ademowo OG. Evaluation of the comparative efficacy and safety of artemether\u2013lumefantrine, artesunate\u2013amodiaquine and artesunate\u2013amodiaquine\u2013chlorpheniramine (Artemoclo\u2122) for the treatment of acute uncomplicated malaria in Nigerian Children. Med Princ Pract. 2014;23:204\u201311.","journal-title":"Med Princ Pract."},{"key":"1963_CR66","doi-asserted-by":"crossref","first-page":"1962","DOI":"10.1093\/infdis\/jiu341","volume":"210","author":"R Tahar","year":"2014","unstructured":"Tahar R, Almelli T, Debue C, Ngane VF, Allico JD, Youdom SW, et al. Randomized trial of artesunate\u2013amodiaquine, atovaquone\u2013proguanil, and artesunate\u2013atovaquone\u2013proguanil for the treatment of uncomplicated falciparum malaria in children. J Infect Dis. 2014;210:1962\u201371.","journal-title":"J Infect Dis"},{"key":"1963_CR67","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1186\/1475-2875-8-148","volume":"8","author":"OA Toure","year":"2009","unstructured":"Toure OA, Penali LK, Yapi JD, Ako BA, Toure W, Djerea K, et al. A comparative, randomized clinical trial of artemisinin\/naphtoquine twice daily one day versus artemether\/lumefantrine six doses regimen in children and adults with uncomplicated falciparum malaria in C\u00f4te d\u2019Ivoire. Malar J. 2009;8:148.","journal-title":"Malar J."},{"key":"1963_CR68","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1186\/1475-2875-8-63","volume":"8","author":"I Sagara","year":"2009","unstructured":"Sagara I, Rulisa S, Mbacham W, Adam I, Sissoko K, Maiga H, et al. Efficacy and safety of a fixed dose artesunate\u2013sulphamethoxypyrazine\u2013pyrimethamine compared to artemether\u2013lumefantrine for the treatment of uncomplicated falciparum malaria across Africa: a randomized multi-centre trial. Malar J. 2009;8:63.","journal-title":"Malar J."},{"key":"1963_CR69","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1186\/1475-2875-9-378","volume":"9","author":"IA Ayede","year":"2010","unstructured":"Ayede IA, Falade AG, Sowunmi A, Jansen FH. An open randomized clinical trial in comparing two artesunate-based combination treatments on Plasmodium falciparum malaria in Nigerian children: artesunate\/sulphamethoxypyrazine\/pyrimethamine (fixed dose over 24 hours) versus artesunate\/amodiaquine (fixed dose over 48 hours). Malar J. 2010;9:378.","journal-title":"Malar J."},{"key":"1963_CR70","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1016\/S0140-6736(10)60322-4","volume":"375","author":"AK Tshefu","year":"2010","unstructured":"Tshefu AK, Gaye O, Kayentao K, Thompson R, Bhatt KM, Sesay SS, et al. Efficacy and safety of a fixed-dose oral combination of pyronaridine\u2013artesunate compared with artemether\u2013lumefantrine in children and adults with uncomplicated Plasmodium falciparum malaria: a randomized non-inferiority trial. Lancet. 2010;375:1457\u201367.","journal-title":"Lancet"},{"key":"1963_CR71","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1186\/1475-2875-11-364","volume":"11","author":"K Kayentao","year":"2012","unstructured":"Kayentao K, Doumbo OK, P\u00e9nali LK, Offianan AT, Bhatt KM, Kimani J, et al. Pyronaridine\u2013artesunate granules versus artemether\u2013lumefantrine crushed tablets in children with Plasmodium falciparum malaria: a randomized controlled trial. Malar J. 2012;11:364.","journal-title":"Malar J."},{"key":"1963_CR72","doi-asserted-by":"crossref","first-page":"e1001119","DOI":"10.1371\/journal.pmed.1001119","volume":"8","author":"The Four Artemisinin-based Combinations (4ABC) Study Group","year":"2011","unstructured":"The Four Artemisinin-based Combinations (4ABC) Study Group. A head-to-head comparison of four artemisinin-based combinations for treating uncomplicated malaria in African children: a randomized trial. PLoS Med. 2011;8:e1001119.","journal-title":"PLoS Med."},{"key":"1963_CR73","doi-asserted-by":"crossref","first-page":"392","DOI":"10.4269\/ajtmh.2002.67.392","volume":"67","author":"LK Basco","year":"2002","unstructured":"Basco LK, Ndounga M, Ngane VF, Soula G. Molecular epidemiology of malaria in Cameroon. XIV. Plasmodium falciparum chloroquine resistance transporter (PFCRT) gene sequences of isolates before and after chloroquine treatment. Am J Trop Med Hyg. 2002;67:392\u20135.","journal-title":"Am J Trop Med Hyg"},{"key":"1963_CR74","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1186\/s12936-015-0557-y","volume":"14","author":"H Maiga","year":"2015","unstructured":"Maiga H, Djimde AA, Beavogui AH, Toure O, Tekete M, Sangare CPO, et al. Efficacy of sulphadoxine\u2013pyrimethamine\u00a0+\u00a0artesunate, sulphadoxine\u2013pyrimethamine\u00a0+\u00a0amodiaquine, and sulphadoxine\u2013pyrimethamine alone in uncomplicated falciparum malaria in Mali. Malar J. 2015;14:64.","journal-title":"Malar J."}],"container-title":["Malaria Journal"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12936-017-1963-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T20:26:07Z","timestamp":1569961567000},"score":1,"resource":{"primary":{"URL":"http:\/\/malariajournal.biomedcentral.com\/articles\/10.1186\/s12936-017-1963-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8,3]]},"references-count":74,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["1963"],"URL":"https:\/\/doi.org\/10.1186\/s12936-017-1963-0","relation":{},"ISSN":["1475-2875"],"issn-type":[{"value":"1475-2875","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,8,3]]},"article-number":"311"}}